Health
Health·The New York Times·Aug 31, 2026

A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs

Read the full story
1 matched episode

↳ whyAnalyzes the economics behind the $480,000 cancer drug discussed in the article.